Immunosuppressive Agents: all 5,940 studies that test it
Page 27 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Preemptive Co-infiltration of Triamcinolone Acetonide With Ropivacaine for Postoperative Pain in Major Spinal SurgeryCompletedNCT06801587Phase 4
- Three Different Modalities for Treatment of Inflammatory Punctal StenosisCompletedNCT06798025Not applicable
- Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal WomenActive, not recruitingNCT06789900Phase 2
- To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia AreataCompletedNCT06786689Phase 2
- Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaSuspendedNCT06738368Phase 2
- Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff TendinopathyWithdrawnNCT06712290Not applicable
- UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNCT06698744Phase 1
- A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal MalignanciesWithdrawnNCT06690281Phase 2
- ABBA CORD: dCBT w/ Abatacept for aGVHD ProphylaxisSuspendedNCT06680661Phase 2
- A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at HomeSuspendedNCT06639958Not applicable
- Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)CompletedNCT06638879Phase 1
- STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWithdrawnNCT06626256Phase 1
- Assessment of the Efficacy of Topical Curcumin in Treatment of Oral Lichen PlanusCompletedNCT06605911Phase 3
- KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person SyndromeCompletedNCT06588491Phase 2
- Local Methotrexate Injections for the Treatment of Nail PsoriasisTerminatedNCT06578728Phase 4
- ALPP CAR-T Cells for ALPP-Positive Advanced Solid TumorsCompletedNCT06556108Phase 1/2
- A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.CompletedNCT06541678Phase 1
- An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia GravisActive, not recruitingNCT06540144Phase 3
- Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory LymphomaStatus unknownNCT06532643Early Phase 1
- Dimethyl Fumarate in AdrenomyeloneuropathyActive, not recruitingNCT06513533Phase 2/3
- Comparison of the Effectiveness of Single-Dose Methotrexate Protocol With Letrozole + Single-Dose Methotrexate in the Medical Treatment of Patients Diagnosed With Ectopic PregnancyCompletedNCT06504082Not applicable
- Long Term Beta Thalassemia Treatment: Findings From The Extension PeriodActive, not recruitingNCT06490601Phase 2
- The COAT Trial: Cequa's Onset of Action TrialCompletedNCT06482177Phase 4
- A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute LeukemiasWithdrawnNCT06474663Phase 1
- Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLTerminatedNCT06470451Phase 3
- Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS MalignanciesWithdrawnNCT06466798Phase 1
- Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic CancerCompletedNCT06464965Phase 1
- Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic LeukemiaSuspendedNCT06447987Phase 1
- Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAAWithdrawnNCT06424639Phase 4
- A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT06411249Phase 4
- A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic OintmentTerminatedNCT06400511Phase 3
- Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn ManagementWithdrawnNCT06362226Phase 1
- The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen PlanusCompletedNCT06362005Phase 4
- Short Benznidazole Regimen for Chronic Phase Chagas Disease PatientsWithdrawnNCT06339710Phase 3
- Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee OsteoarthritisCompletedNCT06308887Phase 4
- Study in ALS With Abatacept & IL-2CompletedNCT06307301Phase 1
- Efficacy of Combination of Hdroxyurea and Thalidomide Over Hydroxyurea or Thalidomide in the Treatment of Transfusion Dependent Thalassemia in ChildrenCompletedNCT06299670Phase 4
- ZILRETTA in Subjects With Shoulder OsteoarthritisActive, not recruitingNCT06269705Phase 3
- Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic CancerActive, not recruitingNCT06253520Phase 1
- Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)WithdrawnNCT06246786Early Phase 1
- Cladribine Venetoclax in Monocytic AMLActive, not recruitingNCT06232655Phase 2
- Has Ultrasound-guided Hydrorelease of Coracohumeral Ligamet Additional Benefit in Patients With Adhesive Capsulitis Receiving Ultrasound-guided Shoulder Hyrodilatation?CompletedNCT06202963Not applicable
- Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive CapsulitisCompletedNCT06176248Not applicable
- Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune ThrombocytopeniaWithdrawnNCT06176235Phase 2
- Thalidomide and Hydroxyurea Combination in β-Thalassemia PatientsCompletedNCT06153784Phase 2/3
- Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic MelanomaCompletedNCT06151847Phase 2
- A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia GravisCompletedNCT06149559Phase 2/3
- Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia PatientsCompletedNCT06146478Phase 3
- HCT With PTCy in Higher-risk MDSActive, not recruitingNCT06098313Phase 2
- Safety & Efficacy of Thalidomide in Children With Transfusion Dependent ThalassemiaCompletedNCT06098014Phase 1
- Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate CancerWithdrawnNCT06094842Phase 1
- Sirolimus for Improving Social Abilities in People With PTEN Germline MutationsWithdrawnNCT06080165Phase 1/2
- To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLActive, not recruitingNCT06072131Phase 3
- Methotrexate Infusion and Intrasilicone Injection During Diabetic VitrectomyCompletedNCT06038968Early Phase 1
- Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission TomographyCompletedNCT06022068Phase 1/2
- A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous CladribineTerminatedNCT06021600Phase 1
- Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for HypophosphatasiaWithdrawnNCT06015750Phase 4
- Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With KymriahWithdrawnNCT06003179Phase 1
- HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisActive, not recruitingNCT06001385Phase 2
- Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)TerminatedNCT06001125Phase 2
- CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the ElderlyCompletedNCT05996393Phase 4
- A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy ParticipantsCompletedNCT05981976Phase 1
- Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.CompletedNCT05959759Phase 4
- Improving Drop Instillation Comfort of a Cyclosporine A SolutionCompletedNCT05957211Not applicable
- CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNCT05950113Phase 1
- Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic CancerActive, not recruitingNCT05922930Phase 1/2
- Assessment of the Efficacy of Letrozole in the Treatment of Ectopic PregnancyStatus unknownNCT05918718Phase 1/2
- Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid LeukemiaCompletedNCT05906914Phase 2
- Optimal Anesthetic for Corticosteroid Injections for Knee OsteoarthritisCompletedNCT05906433Phase 1
- Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis PatientsActive, not recruitingNCT05902429Phase 4
- Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum DisorderCompletedNCT05896605Phase 4
- High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHDWithdrawnNCT05895201Phase 1/2
- Treatment of Mycosis Fungoides With Hypericin Ointment and Visible LightCompletedNCT05872854Phase 2
- Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)Active, not recruitingNCT05860881Phase 3
- Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness BurnsTerminatedNCT05856994Phase 1
- Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic DermatitisCompletedNCT05844618Phase 4
- Effect of Rapamycin in Ovarian AgingActive, not recruitingNCT05836025Phase 2
- Everolimus Aging StudyCompletedNCT05835999Phase 2
- Addition of Everolimus to Standard of Care in Carcinoma GallbladderStatus unknownNCT05833815Phase 2/3
- Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast CancerActive, not recruitingNCT05826964Phase 2
- A Exploratory Trial of WTX221 in Refractory Gout PatientsStatus unknownNCT05800041Early Phase 1
- Post-transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Dose Reduction: 50 mg/kg vs 25 mg/kgStatus unknownNCT05780554Not applicable
- R-CMOP in Patients With Primary Diffuse Large B-cell LymphomaStatus unknownNCT05777369Not applicable
- Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.CompletedNCT05771012Not applicable
- CAR- PRISM (PRecision Intervention Smoldering Myeloma)Active, not recruitingNCT05767359Phase 2
- Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for Intensive InductionWithdrawnNCT05766514Phase 2
- Insulin and Abatacept in Recently-diagnosed Type 1 DiabetesCompletedNCT05742243Phase 2
- Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic KeratitisCompletedNCT05720715Phase 4
- CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First RemissionActive, not recruitingNCT05707273Phase 1
- Tetrandrine Tablets Used in Hospitalized Adults With COVID-19WithdrawnNCT05697029Phase 4
- Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SSStatus unknownNCT05694130Phase 2/3
- Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment ResponseStatus unknownNCT05692843Phase 4
- Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction SurgeryCompletedNCT05691764Not applicable
- Tacrolimus for Thrombocytopenia in SSStatus unknownNCT05678335Phase 2/3
- REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept StudyCompletedNCT05663944Phase 2
- A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in ChinaCompletedNCT05658484Phase 4
- Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBCActive, not recruitingNCT05645380Phase 2
- A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)Status unknownNCT05625919Phase 1/2
- Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell ArteritisActive, not recruitingNCT05623592Phase 2
- De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) ProphylaxisActive, not recruitingNCT05622318Phase 2